Premium
CHARACTERISTICS, TREATMENT, AND OUTCOMES OF ≥ 80 YEAR OLD PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) ENROLLED TO PROSPECTIVE TRIALS OF THE GERMAN CLL STUDY GROUP
Author(s) -
AlSawaf O.,
Bahlo J.,
Fischer K.,
Herling C.,
Bergmann M.,
Fink A.M.,
Tresckow J.,
Langerbeins P.,
Cramer P.,
Stilgenbauer S.,
Wendtner C.M.,
Eichhorst B.,
Hallek M.,
Goede V.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_88
Subject(s) - medicine , chronic lymphocytic leukemia , clinical trial , proportional hazards model , concomitant , leukemia